TITLE

Malaria chemoprophylactic regimens for travellers

PUB. DATE
February 1994
SOURCE
Bulletin of the World Health Organization;1994, Vol. 72 Issue 2, p307
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article outlines recommendations of the World Health Organization (WHO) regarding the use of chemoprophylactic anti-malaria regimens among travelers. For areas where Plasmodium vivax is the predominant species, chloroquine is recommended. A combination of chloroquine and proguanil is recommended for areas were Plasmodium falciparum resistance to chloroquine has been reported. In southeast Asia, Indochina and Africa, mefloquine is recommended since these areas have Plasmodium falciparum that are highly resistant. For multiple-resistant Plasmodium falciparum, doxycycline is recommended.
ACCESSION #
24756119

 

Related Articles

  • Does public subsidy of the cost of malaria chemoprophylaxis reduce imported malaria? A comparative policy analysis. Neave, Penny E.; Taylor, Steve; Behrens, Ron H. // Malaria Journal;2013, Vol. 12 Issue 1, p1 

    Background: Chemoprophylaxis is recommended for at-risk travellers visiting malaria endemic regions. The majority of travellers with imported malaria have not used this, and travellers visiting friends and relatives have the largest burden of malaria and the lowest compliance to...

  • Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. Rishikesh, Kumar; Kamath, Asha; Hande, Manjunatha H.; Vidyasagar, Sudha; Acharya, Raviraja V.; Acharya, Vasudeva; Belle, Jayaprakash; Shastry, Ananthakrishna B.; Saravu, Kavitha // Malaria Journal;Aug2015, Vol. 14 Issue 1, p1 

    Background: Of late there have been accounts of therapeutic failure and chloroquine resistance in Plasmodium vivax malaria especially from Southeast Asian regions. The present study was conducted to assess the therapeutic efficacy of chloroquine-primaquine (CQ-PQ) combined regimen in a cohort of...

  • Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand. Krudsood, Srivicha; Tangpukdee, Noppadon; Muangnoicharoen, Sant; Thanachartwet, Vipa; Luplertlop, Nutthanej; Srivilairit, Siripan; Wilairatana, Polrat; Kano, Shigeyuki; Ringwald, Pascal; Areesuwan, Sornchai Loo // Korean Journal of Parasitology;Jun2007, Vol. 45 Issue 2, p111 

    Chloroquine remains the drug of choice for the treatment of vivax malaria in Thailand. Mixed infections of falciparum and vivax malaria are also common in South-East Asia. Laboratory confirmation of malaria species is not generally available. This study aimed to find alternative regimens for...

  • Diez años de eficacia terapéutica de la cloroquina en malaria no complicada por Plasmodium vivax, Turbo, Antioquia, años 2002 y 2011. Ríos, Alexandra; Álvarez, Gonzalo; Blair, Silvia // Biomédica: Revista del Instituto Nacional de Salud;sep2013, Vol. 33 Issue 3, p429 

    Introduction: The therapeutic efficacy of antimalarial drugs should be monitored continuously because of the emergence of drug resistance. In Colombia, there are few studies evaluating the efficacy of chloroquine in uncomplicated malaria by Plasmodium vivax. This study evaluated the therapeutic...

  • Malaria eradication and elimination: views on how to translate a vision into reality. Tanner, Marcel; Greenwood, Brian; Whitty, Christopher J. M.; Ansah, Evelyn K.; Price, Ric N.; Dondorp, Arjen M.; von Seidlein, Lorenz; Baird, J. Kevin; Beeson, James G.; Fowkes, Freya J. I.; Hemingway, Janet; Marsh, Kevin; Osier, Faith // BMC Medicine;Jul2015, Vol. 13 Issue 1, p1 

    Although global efforts in the past decade have halved the number of deaths due to malaria, there are still an estimated 219 million cases of malaria a year, causing more than half a million deaths. In this forum article, we asked experts working in malaria research and control to discuss the...

  • NATURAL FOOD SUPPLEMENT TO PREVENT MALARIA. MASON, RICHARD R.; Casper, Corey // Clinical Advisor;Feb2011, Vol. 14 Issue 2, p68 

    The article provides an answer to a question of whether using artemisinins can prevent malaria.

  • Current scenario of control of malaria. Singh, Sarman // Tropical Parasitology;Jul2011, Vol. 1 Issue 2, p52 

    The author discusses the scenario of malaria control in India. The author mentions that malaria is a major health problem in the country and several other tropical countries where it causes death of millions of children, adults and pregnant women. The author notes the treatment of malaria which...

  • Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum. Flegg, Jennifer A.; Patil, Anand P.; Venkatesan, Meera; Roper, Cally; Naidoo, Inbarani; Hay, Simon I.; Sibley, Carol Hopkins; Guerin, Philippe J. // Malaria Journal;2013, Vol. 12 Issue 1, p1 

    Background: Plasmodium falciparum has repeatedly evolved resistance to first-line anti-malarial drugs, thwarting efforts to control and eliminate the disease and in some period of time this contributed largely to an increase in mortality. Here a mathematical model was developed to map the...

  • Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy. Olaosebikan, Rasaq; Ernest, Kolade; Bojang, Kalifa; Mokuolu, Olugbenga; Rehman, Andrea M.; Affara, Muna; Nwakanma, Davis; Kiechel, Jean-René; Ogunkunle, Taofik; Olagunju, Tope; Murtala, Rukayat; Omefe, Peter; Lambe, Tosin; Bello, Surajudeen; Ibrahim, Olayinka; Olorunsola, Benedict; Ojuawo, Ayotade; Greenwood, Brian; Milligan, Paul // Journal of Infectious Diseases;8/15/2015, Vol. 212 Issue 4, p596 

    Background. The stability of the human immunodeficiency virus type 1 (HIV-1) reservoir and the contribution of cellular proliferation to the maintenance of the reservoir during treatment are uncertain. Therefore, we conducted a longitudinal analysis of HIV-1 in T-cell subsets in different tissue...

Share

Other Topics